Removal of body surface area normalisation improves raw-measured glomerular filtration rate estimation by the Chronic Kidney Disease Epidemiology Collaboration equation and drug dosing in the obese

Internal Medicine Journal

Volumn 45, Issue 7, 2015, Pages 766-773

  Chew Harris, J S C ^a,b   Chin, P K L ^b,c   Florkowski, C M ^a,b   George, P ^a,b   Endre, Z ^b,d  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

^d PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Body surface area; CKD EPI; Creatinine; Drug dosing; EGFR; Obese

Indexed keywords

CARBOPLATIN; DIETHYLENEPENTAACETIC ACID TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; PENTETATE TECHNETIUM TC 99M;

ADULT; ARTICLE; BODY MASS; BODY SURFACE; CANCER PATIENT; CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION EQUATION; COMPARATIVE STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MEASUREMENT ACCURACY; OBESITY; PRIORITY JOURNAL; UROGENITAL SYSTEM PARAMETERS; AGED; CHRONIC KIDNEY FAILURE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; YOUNG ADULT;

ADULT; AGED; BODY MASS INDEX; BODY SURFACE AREA; CARBOPLATIN; GLOMERULAR FILTRATION RATE; HUMANS; MIDDLE AGED; OBESITY; RENAL INSUFFICIENCY, CHRONIC; TECHNETIUM TC 99M PENTETATE; YOUNG ADULT;

EID: 84933530768     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12791     Document Type: Article

References (42)

1. Stevens LA, Levey AS. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol 2009; 20: 2305-2313.
2. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
3. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
4. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI etal. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
5. Johnson DW, Jones GR, Mathew TH, Ludlow MJ, Doogue MP, Jose MD etal. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendations. Med J Aust 2012; 197: 224-225.
6. Mathew TH, Johnson DW, Jones GR, Australasian Creatinine Consensus Working G. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust 2007; 187: 459-463.
7. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW etal. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification and stratification. 2003; 139: 137-147.
8. Delanaye P, Radermecker RP, Rorive M, Depas G, Krzesinski JM. Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example. Nephrol Dial Transplant 2005; 20: 2024-2028.
9. Howey O, Chin P. Usage of renal function equations to guide prescribing in general medicine. N Z Med J 2013; 126: 97-99.
10. Jones GR. Estimating renal function for drug dosing decisions. Clin Biochem Rev 2011; 32: 81-88.
11. Chew-Harris JS, Florkowski CM, Elmslie JL, Livesey J, Endre ZH, George PM. Lean mass modulates glomerular filtration rate in males of normal and extreme body composition. Intern Med J 2014; 44: 749-756.
12. Chew-Harris JS, Florkowski CM, George PM, Endre ZH. Comparative performances of the new chronic kidney disease epidemiology equations incorporating cystatin C for use in cancer patients. Asia Pac J Clin Oncol 2015; 11: 142-151.
13. Peters AM, Perry L, Hooker CA, Howard B, Neilly MD, Seshadri N etal. Extracellular fluid volume and glomerular filtration rate in 1878 healthy potential renal transplant donors: effects of age, gender, obesity and scaling. Nephrol Dial Transplant 2012; 27: 1429-1437.
14. Roche Diagnostics GmBH (Mannheim) I. Creatinine PLUS Method, 2014 (V 20.0).
15. Abbott Laboratories. MULTIGENT Creatinine Enzymatic Package Insert. 8L24 edn. 2013; 1-8.
16. Peake M, Whiting M. Measurement of serum creatinine - current status and future goals. Clin Biochem Rev 2006; 27: 173-184.
17. Piéroni L, Delanaye P, Boutten A, Bargnoux A-S, Rozet E, Delatour V etal. A multicentric evaluation of IDMS-traceable creatinine enzymatic assays. Clin Chim Acta 2011; 412: 2070-2075.
18. Hollis S. Analysis of method comparison studies. Ann Clin Biochem 1996; 33: 1-4.
19. Twomey PJ. How to use difference plots in quantitative method comparison studies. Ann Clin Biochem 2006; 43: 124-129.
20. Efron B, Gong G. A leisurely look at the bootstrap, the jackknife, and cross-validation. Am Stat 1983; 37: 36-48.
21. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J etal. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100.
22. Dooley M, Poole S, Rischin D. Dosing of cytotoxic chemotherapy: impact of renal function estimates on dose. Ann Oncol 2013; 24: 2746-2752.
23. Chin P, Florkowski C, Begg E. The performances of the Cockcroft-Gault, Modification of Diet in Renal Disease Study and Chronic Kidney Disease Epidemiology Collaboration equations in predicting gentamicin clearance. Ann Clin Biochem 2013; 50: 546-557.
24. Chin PK, Chew-Harris JS, Florkowski CM, Begg EJ. The performance of contemporary cystatin C-based GFR equations in predicting gentamicin clearance. Br J Clin Pharmacol 2015; 79: 268-277.
25. Redal-Baigorri B, Rasmussen K, Heaf JG. The use of absolute values improves performance of estimation formulae: a retrospective cross sectional study. BMC Nephrol 2013; 14: 271.
26. Lemoine S, Guebre-Egziabher F, Sens F, Nguyen-Tu M-S, Juillard L, Dubourg L etal. Accuracy of GFR estimation in obese patients. Clin J Am Soc Nephrol 2014; 9: 720-727.
27. Rubner M. Über den einfluss der körpergrösse auf stoff-und kraftwechsel. Z Biol 1883; 19: 535-562.
28. Du Bois D, Du Bois EF. Clinical calorimetry: tenth paper a formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-871.
29. Mosteller R. Simplified calculation of body-surface area. N Engl J Med 1987; 317: 1098.
30. Haycock GB, Schwartz GJ, Wisotsky DH. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 1978; 93: 62-66.
31. Slone TH. Body surface area misconceptions1. Risk Anal 1993; 13: 375-377.
32. Gibson S, Numa A. The importance of metabolic rate and the folly of body surface area calculations. Anaesthesia 2003; 58: 50-55.
33. Heaf JG. The origin of the 1·73-m2 body surface area normalization: problems and implications. Clin Physiol Funct Imaging 2007; 27: 135-137.
34. Ministry of Health. Obesity in New Zealand. 2013 [cited 2014 Apr]. Available from URL: http://www.health.govt.nz/our-work/diseases-and-conditions/obesity
35. Mannel RS, Brady MF, Kohn EC, Hanjani P, Hiura M, Lee R etal. A randomized phase III trial of IV carboplatin and paclitaxel× 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol 2011; 122: 89-94.
36. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003; 14: 1480-1486.
37. Chagnac A, Herman M, Zingerman B, Erman A, Rozen-Zvi B, Hirsh J etal. Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant 2008; 23: 3946-3952.
38. Magee GM, Bilous R, Cardwell CR, Hunter SJ, Kee F, Fogarty DG. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 2009; 52: 691-697.
39. Hourdequin K, Schpero W, McKenna D, Piazik B, Larson R. Toxic effect of chemotherapy dosing using actual body weight in obese versus normal-weight patients: a systematic review and meta-analysis. Ann Oncol 2013; 24: 2952-2962.
40. Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM etal. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2012; 30: 1553-1561.
41. Geddes CC, Woo YM, Brady S. Glomerular filtration rate - what is the rationale and justification of normalizing GFR for body surface area? Nephrol Dial Transplant 2008; 23: 4-6.
42. Matzke GR, Aronoff GR, Atkinson AJ, Bennett WM, Decker BS, Eckardt K-U etal. Drug dosing consideration in patients with acute and chronic kidney disease - a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2011; 80: 1122-1137.